Trading Signals: SGEN Stock Price Prediction and Forecast (Fri. May. 30, 2003 - Wed. Dec. 13, 2023)(Seattle Genetics, Inc.)
| SGEN latest price $42.5100 (0.26%) ($41.8700 - $42.9600) on Tue. Sep. 3, 2013. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.04% (three month average) | RSI | 54 | Latest Price | $42.5100(0.26%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | SGEN advances 1.1% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support SGEN advance at 0% a week (0% probability) IWM(31%) QQQ(31%) SPY(31%) XLK(28%) XLY(25%) | Factors Impacting SGEN price | SGEN will decline at least -1.02% in a week (0% probabilities). TLT(-9%) SHY(-4%) IGOV(-3%) TIP(-1%) BNDX(-0%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.02% (StdDev 2.04%) | Hourly BBV | 0 () | Intraday Trend | -0.9% | | | |
|
5 Day Moving Average | $42.25(0.62%) | 10 Day Moving Average | $42.05(1.09%) | 20 Day Moving Average | $41.86(1.55%) | To recent high | -2.2% | To recent low | 43.1% | Market Cap | $7.391b | | | | Seattle Genetics, Inc. is a biotechnology company, which engages in the development and commercialization of antibody-based therapies for the treatment of cancer. Its products include Adcetris and Padcev. The firm is also advancing a pipeline of novel therapies for solid tumors and blood-related cancers. The company was founded by Clay B. Siegall and H. Perry Fell on July 15, 1997 and is headquartered in Bothell, WA. |